Panel Discussion | Who Should Get MCS for High-Risk PCI? Pros and Cons

Sunday, March 8, 2026

3:35 PM - 4:00 PM EST

Location: CRT Center Stage

Moderator(s)

Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

Disclosure(s): No financial relationships to disclose
David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure(s): Brattea Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

Fayaz Shawl, MD, FACC, FACP, FSCAI

Director, Interventional Cardiology
Adventist HeathCare WhiteOak Medical Center
Silver Spring , Maryland, United States

Disclosure(s): No financial relationships to disclose
Itsik Ben-Dor, MD

WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Abdulla A. Damluji, MD, PhD, MBA

Interventional Cardiologist
Cleveland Clinic Foundation
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Arnav Kumar, MD, MSCR

Interventional Cardiologist Structural Heart Valve Specialist Assistant Professor of Medicine
University of Houston, HCA Medical Center
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose
John M. Lasala, MD, PhD, MSCAI

Professor of Medicine; Director, Structural Heart Disease Program
Washington University School of Medicine
St. Louis, Missouri, United States

Disclosure(s): Abbott Vascular Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Hady Lichaa, MD

Interventional Cardiovascular Specialist
Ascension Saint Thomas Hospital
Murfreesboro, Tennessee, United States

Disclosure(s): Medtronic, Surmodics, Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing)
Rajesh Sachdeva, MD, FACC, FSCAI

Associate Professor of Medicine
Emory University School of Medicine, Georgia, United States

Disclosure(s): No financial relationships to disclose
Joseph L. Thomas, MD

Chair, Department of Medicine
Harbor UCLA Medical Center
TORRANCE, California, United States

Disclosure(s): Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Lindsey Cilia, MD: No financial relationships to disclose

David E. Kandzari, MD, FACC, FSCAI: Brattea Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Fayaz Shawl, MD, FACC, FACP, FSCAI: No financial relationships to disclose

Itsik Ben-Dor, MD: No financial relationships to disclose

Abdulla A. Damluji, MD, PhD, MBA: No financial relationships to disclose

Arnav Kumar, MD, MSCR: No financial relationships to disclose

John M. Lasala, MD, PhD, MSCAI: Abbott Vascular Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore and Associates, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Hady Lichaa, MD: Medtronic, Surmodics, Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing)

Rajesh Sachdeva, MD, FACC, FSCAI: No financial relationships to disclose

Joseph L. Thomas, MD: Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)